Significant overexpression of LPAR3 has been identified in HCC tumor margins and was interestingly overexpressed in the CCA portion of combined HCC-CCA, potentially owing to the increased aggressiveness along with NEFL and TUSC7 that were also overexpressed in the CCA portions [83]. Here, LPAR3 is linked to cholangiocarcinoma.